Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Weitz

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Chest|October 1, 1995
New antithromboticsJ I Weitz, R M Califf, J S Ginsberg, et al.
Laboratory Animal Science|June 1, 1996
An oral ivermectin regimen that eradicates pinworms (Syphacia spp.) in laboratory rats and miceP Klement, J M Augustine, K H Delaney, et al.
The Journal of Biological Chemistry|September 6, 2000
Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activatorR J Stewart, J C Fredenburgh, J A Rischke, et al.
Annals of Internal Medicine|November 1, 1987
Increased neutrophil elastase activity in cigarette smokersJ I Weitz, K A Crowley, S L Landman, et al.
Blood|April 1, 1986
Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42J I Weitz, J A Koehn, R E Canfield, et al.
The Journal of Clinical Investigation|July 1, 1986
Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiencyJ I Weitz, S L Landman, K A Crowley, et al.
Thrombosis and Haemostasis|February 28, 2014
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbitsJ W Yau, P Liao, J C Fredenburgh, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2015
Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cellsC Wu, P Y Kim, L L Swystun, et al.
The Journal of Invasive Cardiology|January 13, 2001
Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?F Feit, J A Bittl, N M Keller, et al.
Circulation|January 7, 1997
Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfateB Cosmi, J C Fredenburgh, J Rischke, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Chest|October 1, 1995
New antithromboticsJ I Weitz, R M Califf, J S Ginsberg, et al.
Laboratory Animal Science|June 1, 1996
An oral ivermectin regimen that eradicates pinworms (Syphacia spp.) in laboratory rats and miceP Klement, J M Augustine, K H Delaney, et al.
The Journal of Biological Chemistry|September 6, 2000
Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activatorR J Stewart, J C Fredenburgh, J A Rischke, et al.
Annals of Internal Medicine|November 1, 1987
Increased neutrophil elastase activity in cigarette smokersJ I Weitz, K A Crowley, S L Landman, et al.
Blood|April 1, 1986
Development of a radioimmunoassay for the fibrinogen-derived peptide B beta 1-42J I Weitz, J A Koehn, R E Canfield, et al.
The Journal of Clinical Investigation|July 1, 1986
Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiencyJ I Weitz, S L Landman, K A Crowley, et al.
Thrombosis and Haemostasis|February 28, 2014
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbitsJ W Yau, P Liao, J C Fredenburgh, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2015
Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cellsC Wu, P Y Kim, L L Swystun, et al.
The Journal of Invasive Cardiology|January 13, 2001
Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?F Feit, J A Bittl, N M Keller, et al.
Circulation|January 7, 1997
Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfateB Cosmi, J C Fredenburgh, J Rischke, et al.
Pageof 14